CSIMarket
 


Bio rad Laboratories Inc   (BIO)
Other Ticker:  
 

Cumulative Bio Rad Laboratories Inc 's Working Capital Ratio for Trailing Twelve Months Period

BIO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

BIO Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth -15.17 % -3.27 % -5.63 % -9.5 % -11.76 %
Y / Y Current Assets Growth -3.47 % 0.21 % -3.41 % -0.79 % 58.77 %
Working Capital Ratio for Trailing Twelve Months Period 6 5.82 5.77 5.73 5.6
Total Ranking # 305 # 610 # 671 # 760 # 902
Seq. Current Liabilities Growth -7.06 % -4.84 % -1.45 % -2.68 % 5.98 %
Seq. Current Assets Growth -3.13 % 0.25 % -4.22 % 3.78 % 0.57 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Current Liabilities decreased faster than Bio Rad Laboratories Inc 's average Current Assets, this led to increase in in Bio Rad Laboratories Inc 's Working Capital Ratio for Trailing Twelve Months Period to 6, Working Capital Ratio for Trailing Twelve Months Period remained below Bio rad Laboratories Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Laboratory Analytical Instruments industry 2 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Bio Rad Laboratories Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about BIO
Working Capital Ratio BIO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 3
Sector # 137
S&P 500 # 251


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.6 4.06 2.36
(Dec 31 2023)   (Sep 30 2020)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Laboratory Analytical Instruments Industry Working Capital Ratio for Trailing Twelve Months Period
Quanterix Corp  11.29 
Talis Biomedical Corporation  10.48 
Reflect Scientific Inc   9.91 
Rapid Micro Biosystems Inc   7.92 
Cytek Biosciences Inc   7.68 
Lifeloc Technologies Inc   6.41 
Bio rad Laboratories Inc   5.95 
10x Genomics Inc   5.37 
Olink Holding Ab publ   4.80 
Scientific Industries Inc   4.64 
Pacific Biosciences Of California Inc   4.28 
Prenetics Global Limited  4.23 
Standard Biotools Inc   4.13 
Isoplexis Corporation  4.06 
Cue Health Inc   3.99 
Codex Dna Inc   3.96 
Eyepoint Pharmaceuticals Inc   3.73 
Bionano Genomics Inc   3.54 
Phenomex Inc   3.32 
Akoya Biosciences Inc   3.03 
Agilent Technologies inc   2.35 
Perkinelmer Inc  2.28 
Bruker Corporation  2.23 
Kewaunee Scientific Corporation  2.22 
Harvard Bioscience Inc  2.09 
Revvity Inc   2.01 
Htg Molecular Diagnostics Inc  1.67 
Avantor Inc   1.60 
Illumina Inc   1.47 
Mettler toledo International Inc   1.24 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com